Mometasone furoate nasal spray in Italian children with seasonal allergic rhinitis: a comprehensive assessment

CONCLUSIONS: The present study documented that a 3-week MFNS treatment was able to significantly dampen type 2 inflammation, improve QoL, and reduce severity of symptoms in Italian children with SAR, and was safe.PMID:36086965 | DOI:10.15586/aei.v50i5.643

Source: Allergologia et Immunopathologia - September 10, 2022 Category: Allergy & Immunology Authors: Cristiana Indolfi Giulio Dinardo Giuseppina Rosaria Umano Angela Klain Marcella Contieri Alberto Decimo Fabio Decimo Giorgio Ciprandi Michele Miraglia Del Giudice Source Type: research